U.S. Infrastructure Stock News

NYSE:FLUT
NYSE:FLUTHospitality

Flutter Entertainment Reassesses Growth As FanDuel Predicts Faces Regulatory Tests

Flutter Entertainment, NYSE:FLUT, missed recent revenue expectations and issued guidance for 2026 that some investors view as cautious. The company has launched FanDuel Predicts, expanding into prediction markets at a time when regulators are paying closer attention to the sector. These moves come as competition in online wagering and prediction products intensifies, raising questions about Flutter Entertainment's next phase of growth. For shareholders, the backdrop is already challenging...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Is Affirm Holdings (AFRM) Pricing In Too Much Optimism After Recent Share Price Declines?

If you are wondering whether Affirm Holdings at around US$46.98 still makes sense for your portfolio, it helps to step back and look at what the current price might already be assuming about the business. The stock has been volatile recently, with a 7 day return of 8% decline, a 30 day return of 25.2% decline, a year to date return of 36.5% decline, a 1 year return of 26.8% decline and a 3 year return that is very large compared to its 5 year return of 42.1% decline. Recent moves have come...
NYSE:TFC
NYSE:TFCBanks

A Look At Truist Financial (TFC) Valuation After Morgan Stanley Upgrade And Buyback Expectations

Morgan Stanley’s upgrade of Truist Financial (TFC) has put fresh attention on the stock, with the firm pointing to an estimated US$14.6b in excess capital and a more active buyback outlook. See our latest analysis for Truist Financial. Despite the recent analyst upgrade and news around leadership hires, Truist Financial’s 1-day share price return of 4.25% and 7-day share price return of 5.75% show some investors reassessing the near term. At the same time, a 90-day share price return of 5.88%...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Why MannKind (MNKD) Is Down 40.8% After Earnings Miss And New Tyvaso DPI Rival Appears

MannKind Corporation reported past fourth-quarter 2025 results with revenue rising to US$111.96 million, but swinging from prior net income to a US$15.95 million net loss, while full-year 2025 revenue increased to US$348.97 million alongside a lower net income of US$5.86 million. A key risk emerged as partner United Therapeutics recently unveiled a competing soft-mist treprostinil inhaler that could challenge MannKind’s Tyvaso DPI royalty stream, increasing uncertainty around the company’s...
NYSE:DEA
NYSE:DEAOffice REITs

A Look At Easterly Government Properties (DEA) Valuation As Recent Momentum Meets Mixed Long Term Returns

Easterly Government Properties (DEA) focuses on Class A properties leased to U.S. government agencies, and its stock has seen mixed returns, with a monthly gain alongside a negative 1-year total return. See our latest analysis for Easterly Government Properties. At a share price of $23.28, Easterly Government Properties has a 30 day share price return of 3.28% and a year to date share price return of 9.24%. The 1 year total shareholder return of 9.89% and 5 year total shareholder return of...
NasdaqCM:RCAT
NasdaqCM:RCATAerospace & Defense

Assessing Red Cat Holdings (RCAT) Valuation After New Defense Rules And Pentagon Drone Contract

The immediate implementation of Section 1709 of the FY25 NDAA, which restricts foreign-made drone components, together with a new Pentagon Drone Dominance Program contract, has put fresh attention on Red Cat Holdings (RCAT) and its expanding unmanned systems portfolio. See our latest analysis for Red Cat Holdings. At a share price of $11.65, Red Cat has seen a 67.14% 90 day share price return and a very large 3 year total shareholder return. However, recent 1 day and 30 day share price moves...
NYSE:SDRL
NYSE:SDRLEnergy Services

Seadrill’s Record Safety And Contract Wins Set Stage For 2026 Earnings

Seadrill (NYSE:SDRL) reported record operational and safety performance, marking its best safety results to date. The company secured several long term contracts, including a key award in Malaysia in the deepwater segment. Management highlighted strong execution on complex offshore projects alongside ongoing market challenges such as high reactivation costs and regional softness. At a share price of $43.88, Seadrill is drawing attention as it pairs operational execution with what the...
NYSE:CRCL
NYSE:CRCLSoftware

Circle Internet Group (CRCL) Valuation After Q4 Beat And USDC Growth Fuels Renewed Investor Optimism

Circle Internet Group (CRCL) is back in focus after its fourth quarter 2025 earnings comfortably beat forecasts on revenue and profitability, helped by stronger USDC usage, heavier onchain volumes, and higher reserve income. See our latest analysis for Circle Internet Group. After the initial post earnings surge, Circle Internet Group’s recent 7 day share price return of 32.4% and 30 day share price return of 23.5% suggest momentum is still building despite a softer 1 day move. If Circle’s...
NYSE:BOX
NYSE:BOXSoftware

How Box’s AI Contract Automation Deal with RWS Global Could Shape Box (BOX) Investors’ Outlook

In February 2026, RWS Global announced it had selected Box as its Intelligent Content Management partner, adopting Box Enterprise Advanced and Box AI to modernize how vast volumes of unstructured content are governed, automated and embedded into workflows across its global experiential operations. A distinctive aspect of this partnership is RWS Global’s use of Box’s AI-powered contract automation, which cuts contract processing times from up to 20 minutes to under two minutes per contract,...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

What Tower Semiconductor (TSEM)'s Expanded Silicon Photonics Manufacturing Role Means For Shareholders

In February 2026, Tower Semiconductor and partners Salience Labs, Xanadu, and Scintil Photonics announced expanded collaborations to manufacture advanced silicon photonics solutions for AI data centers and photonic quantum computing, moving several programs onto Tower's high-volume platforms and into pre-production readiness. These deals collectively highlight Tower's role as a manufacturing backbone for cutting-edge photonic technologies that could underpin next-generation AI networking and...
NYSE:AHR
NYSE:AHRHealth Care REITs

Is It Too Late To Consider American Healthcare REIT (AHR) After An 80% One-Year Rally?

If you are wondering whether American Healthcare REIT is attractively priced at around US$52.24, you are not alone. Many investors are asking if the recent run reflects its true value or if there is still room on the table. The stock has returned 0.6% over the last 7 days, 10.6% over the past month, and 80.1% over the past year, which naturally raises questions about how risk and reward now stack up. Recent coverage has focused on American Healthcare REIT as a healthcare focused real estate...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

Phathom Pharmaceuticals (PHAT) Is Up 10.0% After Guiding to 2026 Operating Profitability and Raising Capital

In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a much smaller net loss of US$21.15 million for the quarter and US$221.25 million for the year, alongside guidance for 2026 that includes expected operating profitability (excluding stock-based compensation) beginning in the third quarter. The company also strengthened its financial position through a US$130 million equity raise, reworked term loans, and ongoing uptake of its VOQUEZNA...
NYSE:ABR
NYSE:ABRMortgage REITs

Arbor Realty Trust (ABR) Dividend Coverage Concerns Reinforce Bearish Narratives

Arbor Realty Trust (ABR) just closed out FY 2025 with Q4 revenue of US$81.3 million and basic EPS of US$0.07, capping a year where trailing twelve month revenue came in at US$467.7 million and EPS at US$0.56. Over recent quarters the company has seen quarterly revenue range from US$111.1 million to US$140.7 million with EPS between US$0.12 and US$0.20, while trailing twelve month revenue has moved between US$467.7 million and US$650.4 million and EPS between US$0.56 and US$1.35. This sets the...
NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

Assessing AvePoint (AVPT) Valuation After Strong 2025 Results And AI Governance Growth Outlook

AvePoint (AVPT) is back in focus after reporting Q4 and full year 2025 earnings, issuing 2026 revenue guidance, and filing a US$206.96 million shelf registration tied to an employee stock ownership plan. See our latest analysis for AvePoint. The earnings beat and AI-focused product updates have coincided with a 3.85% 1 day share price return. However, the 30 day and year to date share price returns of 9.56% and 18.46% declines, and a 27.84% decline in the 1 year total shareholder return,...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

Is It Time To Reassess NetScout Systems (NTCT) After Its 30% One-Year Share Price Gain?

If you are wondering whether NetScout Systems is priced attractively right now, the recent share performance gives you a useful starting point but not the full story on value. The stock closed at US$29.21, with a 1.6% decline over the last 7 days, a 4.1% gain over 30 days, an 8.8% gain year to date, and a 29.9% return over the past year, while the 3 year and 5 year returns sit at 3.2% and 6.3% respectively. These moves come against a backdrop of ongoing interest in networking and...
NasdaqGM:VITL
NasdaqGM:VITLFood

Assessing Vital Farms (VITL) Valuation After Recent Share Price Weakness

Vital Farms stock moves after recent performance Vital Farms (VITL) has drawn investor attention after recent share price pressure, with the stock showing negative returns over the past week, month and past 3 months, prompting closer scrutiny of its current valuation. See our latest analysis for Vital Farms. At a share price of $21.09, Vital Farms has seen momentum fade recently, with a 30 day share price return of 25.87% and a 1 year total shareholder return of 36.3%, set against a 3 year...
NYSE:LEVI
NYSE:LEVILuxury

Levi Strauss Dockers Peru Sale Refocuses Portfolio And Valuation Story

Levi Strauss (NYSE:LEVI) has agreed to sell its Dockers casualwear business in Peru to Authentic Brands Group. The transaction involves the Dockers brand rights in the Peruvian market and reflects a change in how Levi Strauss manages parts of its portfolio. Investors are watching how the divestiture could reshape Levi Strauss's regional focus and operational footprint. Levi Strauss, best known for its Levi's denim line, has long used Dockers to reach consumers looking for casual, non denim...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Is It Too Late To Consider ACM Research (ACMR) After Its 115% One Year Surge?

If you are wondering whether ACM Research at around US$55.68 is still good value after its big run, you are not alone. This article is designed to help you make sense of what that price might imply. The stock has been volatile recently, with a 16.4% decline over the last 7 days, a 1.8% gain over 30 days, and returns of 24.1% year to date and 114.6% over the past year, while the 3 year return is very large and the 5 year return is 89.6%. Recent attention on semiconductor related names, as...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

Truth Social Spin Off And TAE Merger Reshape Trump Media Exposure

Trump Media & Technology Group (NasdaqGM:DJT) is in advanced talks to spin off its Truth Social platform into a separate publicly traded company. The possible transaction would follow completion of Trump Media's planned merger with fusion energy firm TAE Technologies. The move would represent a major reshaping of Trump Media's assets across social media and energy businesses. For you as an investor, the headline is that Trump Media & Technology Group, known primarily for its Truth Social...
NasdaqCM:AXGN
NasdaqCM:AXGNMedical Equipment

Why Axogen (AXGN) Is Down 10.1% After Avance FDA Win and 2026 Guidance Shift

In February 2026, Axogen reported full-year 2025 results showing sales of US$225.21 million versus US$187.34 million in 2024, alongside a wider net loss of US$15.70 million and basic loss per share of US$0.34, while also issuing 2026 guidance for at least 18% revenue growth to about US$265.70 million with a 74%–76% gross margin range. These results coincided with U.S. FDA approval of Avance as the first biologic for peripheral nerve discontinuities with 12 years of market exclusivity, debt...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft Detroit Fatal Crash Puts Rideshare Safety And Regulation Under Scrutiny

A Lyft driver in Detroit has been charged with multiple felony counts, including second-degree murder, following a crash that killed two passengers. The incident involved a Lyft ride that ended in a fatal collision, raising questions about rider safety and driver behavior on the platform. The case brings fresh attention to Lyft's (NasdaqGS:LYFT) safety policies, driver vetting, and potential legal exposure. Lyft operates a rideshare platform that connects riders with drivers, competing...
NYSE:SHW
NYSE:SHWChemicals

Sherwin-Williams Extends 47-Year Dividend Streak As Income Story Evolves

Sherwin-Williams (NYSE:SHW) has approved its 47th consecutive annual dividend increase. The board decision extends a dividend growth streak that now spans nearly five decades. The move underscores the company’s ongoing focus on returning cash to shareholders. Sherwin-Williams, a major player in paints and coatings for residential, commercial, and industrial customers, now adds another year to its dividend growth record. For income focused investors, a streak of 47 consecutive annual...
NYSE:FRO
NYSE:FROOil and Gas

Frontline (NYSE:FRO) Margin Compression Challenges Bullish Earnings Growth Narrative

Frontline (NYSE:FRO) has capped FY 2025 with fourth quarter revenue of US$624.5 million and EPS of US$1.02, while trailing twelve month revenue sits at US$1.97 billion and EPS at US$1.70. The company has seen quarterly revenue move from US$425.6 million and EPS of US$0.30 in Q4 2024 to US$624.5 million and EPS of US$1.02 in Q4 2025, giving investors a clear view of how the top line and per share earnings have tracked over the past year as they weigh these results against margins and overall...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

HealthEquity’s HSA Growth And Reaffirmed Outlook Might Change The Case For Investing In HQY

In late February 2026, HealthEquity reported solid year-over-year growth in health savings accounts and assets, while reaffirming its outlook for fiscal 2026 and 2027, signaling continued confidence in its business trajectory. This combination of expanding HSA activity and maintained guidance underlines how HealthEquity is benefiting from growing demand for tax-advantaged healthcare spending and savings solutions. Next, we'll examine how reaffirmed multi-year guidance may influence...